Search results
Results From The WOW.Com Content Network
Alcon offices in Johns Creek, Georgia. Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
ADK's pharmaceutical operations have expanded significantly over the past 17 years and it is today the largest wholesale distributor as well as retailer of pharmaceutical products in the country. Currently, ADK operates 5 pharmacies in Malé, 1 in Vilimalé and an optical showroom, with exclusive rights to advertise and sell Alcon ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
On July 14, 2020, Wedgewood Partners released its Q2 2020 Investor Letter, a copy of which you can download here. The Fund returned 27.13% for the second quarter of 2020. Meanwhile, the benchmark ...
A holiday in Japan made for thin trading and MSCI's broadest index of Asia-Pacific shares outside Japan was little changed, after bouncing 2.7% last week. Japan's Nikkei was shut but futures were ...
www.hovid.com. Hovid Berhad (Chinese: 何人可有限公司; MYX: 7213) is a Malaysian health care provider and pharmaceutical company. It was founded in the early 1940s. The company's headquarters are located in Ipoh, the capital city of Perak state, Malaysia. [1] It was formerly known as Ho Yan Hor Sdn Bhd (Chinese: 何人可私人有限公司).
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients ...